Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
You’re invited to join our “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now. MGFA is offering this online webinar program series to anyone interested in learning more about this ongoing MG research in investigative therapies. We hope you’ll register for the latest update.
Targeted Cell Therapy for Patients with MuSK Myasthenia Gravis
Date/Time: Tuesday, October 5th 2021 at 2:00 p.m. Eastern
Presenter: David J. Chang, MD MPH, Cabaletta Bio
The presentation will provide information about the development of cell therapy, a novel precision medicine approach for treating conditions such as cancer and autoimmune diseases. In addition, the education session will present advances in highly targeted cell therapy with chimeric autoantibody receptor T cells (CAART) for the potential treatment of patients with muscle-specific kinase (MuSK) myasthenia gravis and other related autoimmune diseases. Finally, the webinar will discuss the planned Phase 1 clinical trial of Autologous MuSK Chimeric Autoantibody Receptor T Cells (MuSK-CAART) in patients with MuSK myasthenia gravis.
Register for This Webinar
We Thank Our Generous Sponsors